These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 31707671)

  • 1. Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral Vectors.
    Mo F; Mamonkin M
    Methods Mol Biol; 2020; 2086():119-130. PubMed ID: 31707671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of CAR T-cells using γ-retroviral vector.
    Watanabe N; McKenna MK
    Methods Cell Biol; 2022; 167():171-183. PubMed ID: 35152995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized Production of Lentiviral Vectors for CAR-T Cell.
    Moço PD; de Abreu Neto MS; Fantacini DMC; Picanço-Castro V
    Methods Mol Biol; 2020; 2086():69-76. PubMed ID: 31707668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteria-free minicircle DNA system to generate integration-free CAR-T cells.
    Cheng C; Tang N; Li J; Cao S; Zhang T; Wei X; Wang H
    J Med Genet; 2019 Jan; 56(1):10-17. PubMed ID: 30030293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAVS1 site-specific integration of the CAR gene into human primary T cells using a linear closed-ended AAV-based DNA vector.
    Chen W; Tan L; Zhou Q; Li W; Li T; Zhang C; Wu J
    J Gene Med; 2020 Apr; 22(4):e3157. PubMed ID: 31901177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-Based CAR T Cells Produced by Lentiviral Transduction.
    Prommersberger S; Hudecek M; Nerreter T
    Curr Protoc Immunol; 2020 Mar; 128(1):e93. PubMed ID: 32150338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis and optimization of protocols for producing recombinant lentivirus carrying the anti-Her2 chimeric antigen receptor gene.
    Yuan W; Chen J; Cao Y; Yang L; Shen L; Bian Q; Bin S; Li P; Cao J; Fang H; Gu H; Li H
    J Gene Med; 2018 Jul; 20(7-8):e3027. PubMed ID: 29851200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches of T Cell Activation and Differentiation for CAR-T Cell Therapies.
    Schwab RD; Bedoya DM; King TR; Levine BL; Posey AD
    Methods Mol Biol; 2020; 2086():203-211. PubMed ID: 31707678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression.
    Lanitis E; Rota G; Kosti P; Ronet C; Spill A; Seijo B; Romero P; Dangaj D; Coukos G; Irving M
    J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33156338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAR T Cells Generated Using Sleeping Beauty Transposon Vectors and Expanded with an EBV-Transformed Lymphoblastoid Cell Line Display Antitumor Activity In Vitro and In Vivo.
    Chicaybam L; Abdo L; Carneiro M; Peixoto B; Viegas M; de Sousa P; Fornazin MC; Spago MC; Albertoni Laranjeira AB; de Campos-Lima PO; Nowill A; Barros LRC; Bonamino MH
    Hum Gene Ther; 2019 Apr; 30(4):511-522. PubMed ID: 30793967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.
    Drent E; Poels R; Ruiter R; van de Donk NWCJ; Zweegman S; Yuan H; de Bruijn J; Sadelain M; Lokhorst HM; Groen RWJ; Mutis T; Themeli M
    Clin Cancer Res; 2019 Jul; 25(13):4014-4025. PubMed ID: 30979735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies.
    Mamonkin M; Mukherjee M; Srinivasan M; Sharma S; Gomes-Silva D; Mo F; Krenciute G; Orange JS; Brenner MK
    Cancer Immunol Res; 2018 Jan; 6(1):47-58. PubMed ID: 29079655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells.
    Xiong W; Chen Y; Kang X; Chen Z; Zheng P; Hsu YH; Jang JH; Qin L; Liu H; Dotti G; Liu D
    Mol Ther; 2018 Apr; 26(4):963-975. PubMed ID: 29503199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity.
    Torres Chavez A; McKenna MK; Canestrari E; Dann CT; Ramos CA; Lulla P; Leen AM; Vera JF; Watanabe N
    J Immunother Cancer; 2019 Nov; 7(1):330. PubMed ID: 31779709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Cell and Genome Modification Technologies to Generate Improved "Off-the-Shelf" CAR T and CAR NK Cells.
    Morgan MA; Büning H; Sauer M; Schambach A
    Front Immunol; 2020; 11():1965. PubMed ID: 32903482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR.
    Straetemans T; Kierkels GJJ; Doorn R; Jansen K; Heijhuurs S; Dos Santos JM; van Muyden ADD; Vie H; Clemenceau B; Raymakers R; de Witte M; Sebestyén Z; Kuball J
    Front Immunol; 2018; 9():1062. PubMed ID: 29899740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21.
    Ptáčková P; Musil J; Štach M; Lesný P; Němečková Š; Král V; Fábry M; Otáhal P
    Cytotherapy; 2018 Apr; 20(4):507-520. PubMed ID: 29475789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic Analysis of CAR-T Cells.
    de Azevedo JTC; Mizukami A; Moço PD; Malmegrim KCR
    Methods Mol Biol; 2020; 2086():195-201. PubMed ID: 31707677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral Engineering of Chimeric Antigen Receptor Expression on Murine and Human T Lymphocytes.
    Hammill JA; Afsahi A; Bramson JL; Helsen CW
    Methods Mol Biol; 2016; 1458():137-57. PubMed ID: 27581020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
    Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
    Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.